WO2024045049A1 - Composition for caring for keratin materials and mask containing the same - Google Patents
Composition for caring for keratin materials and mask containing the same Download PDFInfo
- Publication number
- WO2024045049A1 WO2024045049A1 PCT/CN2022/116226 CN2022116226W WO2024045049A1 WO 2024045049 A1 WO2024045049 A1 WO 2024045049A1 CN 2022116226 W CN2022116226 W CN 2022116226W WO 2024045049 A1 WO2024045049 A1 WO 2024045049A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- ascorbyl
- mask
- hydroxyhydrocinnamate
- alginate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 239000000463 material Substances 0.000 title claims abstract description 29
- 102000011782 Keratins Human genes 0.000 title claims abstract description 27
- 108010076876 Keratins Proteins 0.000 title claims abstract description 27
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 41
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 40
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 38
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 22
- 229940108325 retinyl palmitate Drugs 0.000 claims description 22
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 22
- 239000011769 retinyl palmitate Substances 0.000 claims description 22
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 20
- 229940072056 alginate Drugs 0.000 claims description 20
- 235000010443 alginic acid Nutrition 0.000 claims description 20
- 229920000615 alginic acid Polymers 0.000 claims description 20
- 239000003963 antioxidant agent Substances 0.000 claims description 20
- 235000006708 antioxidants Nutrition 0.000 claims description 20
- 235000010323 ascorbic acid Nutrition 0.000 claims description 19
- 239000011668 ascorbic acid Substances 0.000 claims description 19
- 229960005070 ascorbic acid Drugs 0.000 claims description 19
- 230000003078 antioxidant effect Effects 0.000 claims description 18
- 229960003471 retinol Drugs 0.000 claims description 17
- 235000020944 retinol Nutrition 0.000 claims description 17
- 239000011607 retinol Substances 0.000 claims description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 15
- 235000010384 tocopherol Nutrition 0.000 claims description 15
- 229960001295 tocopherol Drugs 0.000 claims description 15
- 229930003799 tocopherol Natural products 0.000 claims description 15
- 239000011732 tocopherol Substances 0.000 claims description 15
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- VOXXWSYKYCBWHO-UHFFFAOYSA-N 3-phenyllactic acid Chemical compound OC(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-N 0.000 claims description 12
- -1 ascorbyl methylsilanol Chemical compound 0.000 claims description 11
- 150000004492 retinoid derivatives Chemical class 0.000 claims description 11
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 8
- 229940067599 ascorbyl glucoside Drugs 0.000 claims description 8
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 6
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 6
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 claims description 6
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims description 6
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 6
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 6
- 229930002330 retinoic acid Natural products 0.000 claims description 6
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical group CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 claims description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 5
- 239000000648 calcium alginate Substances 0.000 claims description 4
- 235000010410 calcium alginate Nutrition 0.000 claims description 4
- 229960002681 calcium alginate Drugs 0.000 claims description 4
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- SSDSCDGVMJFTEQ-UHFFFAOYSA-N octadecyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 SSDSCDGVMJFTEQ-UHFFFAOYSA-N 0.000 claims description 4
- 229940059574 pentaerithrityl Drugs 0.000 claims description 4
- 230000002207 retinal effect Effects 0.000 claims description 4
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 claims description 4
- 229960001727 tretinoin Drugs 0.000 claims description 4
- DWMGLUVISSMERV-BBIVZNJYSA-N (2r)-2-[(1s)-2-[dihydroxy(methyl)silyl]oxy-1-hydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound C[Si](O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DWMGLUVISSMERV-BBIVZNJYSA-N 0.000 claims description 3
- MFCMBWRHOUCXEZ-CAHLUQPWSA-N 3-aminopropyl [(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] hydrogen phosphate Chemical compound NCCCOP(O)(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O MFCMBWRHOUCXEZ-CAHLUQPWSA-N 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 claims description 3
- RIQIJXOWVAHQES-UNAKLNRMSA-N Tocoretinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C RIQIJXOWVAHQES-UNAKLNRMSA-N 0.000 claims description 3
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 claims description 3
- PRFQZMITZQNIQW-SAMIYVOISA-N [(2s)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O PRFQZMITZQNIQW-SAMIYVOISA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229930002945 all-trans-retinaldehyde Natural products 0.000 claims description 3
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 claims description 3
- 235000010376 calcium ascorbate Nutrition 0.000 claims description 3
- 229940047036 calcium ascorbate Drugs 0.000 claims description 3
- 239000011692 calcium ascorbate Substances 0.000 claims description 3
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- AMQDHYXCJCIBQJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1[O-] AMQDHYXCJCIBQJ-YCWPWOODSA-L 0.000 claims description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 3
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 3
- 229940095136 methylsilanol ascorbate Drugs 0.000 claims description 3
- 229940049964 oleate Drugs 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 claims description 3
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 claims description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 3
- BZZNGXDPFQVTCP-JFDGLQCVSA-M sodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] phosphate Chemical compound [Na+].O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)P([O-])(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O BZZNGXDPFQVTCP-JFDGLQCVSA-M 0.000 claims description 3
- 229940119168 tetrahexyldecyl ascorbate Drugs 0.000 claims description 3
- 229950009883 tocopheryl nicotinate Drugs 0.000 claims description 3
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 3
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 239000011572 manganese Substances 0.000 claims description 2
- 229910052712 strontium Inorganic materials 0.000 claims description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000003921 oil Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 13
- 239000002537 cosmetic Substances 0.000 description 11
- 239000000835 fiber Substances 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 235000020945 retinal Nutrition 0.000 description 4
- 239000011604 retinal Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000433 Lyocell Polymers 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-HPNHMNAASA-N 11-cis-retinol Natural products OCC=C(C)C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-HPNHMNAASA-N 0.000 description 1
- FPIPGXGPPPQFEQ-HWCYFHEPSA-N 13-cis-retinol Chemical compound OC/C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-HWCYFHEPSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-MKOSUFFBSA-N 9-cis-retinol Chemical compound OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-MKOSUFFBSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910018557 Si O Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FPIPGXGPPPQFEQ-DPZDGVIMSA-N dihydroretinol Natural products CC(=CCO)C=CC=C(C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-DPZDGVIMSA-N 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 description 1
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Definitions
- the present invention relates to a cosmetic composition and mask containing the same.
- the present invention relates to a composition for caring for keratin materials and a mask containing the same, as well as a non-therapeutic process for caring for keratin materials with said composition or mask.
- Skin is the protective barrier for the human body. It protects the interior of the body form physical injury (such as trauma) and biological injury (such as bacterial, viruses or fungi) .
- Skin aging is part of the aging process of human body, which not only relates to the age itself, but also closely relates to external factors, such as sunlight exposure.
- the light induced skin aging ( “light-aging” ) is mainly caused by sunlight irradiation, and as depletion of the ozone layer is aggravating, the light-aging of the skin becomes more and more serious, which affects the appearance of the skin.
- lipophilic active ingredient such as retinoids cannot be delivered into the skin effectively.
- the present invention provides a composition for caring for keratin materials, comprising:
- the present invention provides a mask for caring for keratin materials, comprising:
- the present invention also provides a non-therapeutic process for caring for keratin materials, in particular the skin, comprising the step of applying the composition or the mask according to the present invention on the keratin materials.
- retinoids are stable for a relatively long term and can be delivered into the skin effectively.
- keratin material is intended to cover the skin. Facial skin and eye skin are most particularly considered according to the present invention.
- stable means that retinol or its derivatives contained in the mask will not decompose substantially for at least 2 months.
- composition for caring for keratin materials comprises:
- the composition according to the present invention comprises at least one retinoid.
- the retinoids according to the present invention include retinol (vitamin A) , retinal (vitamin A aldehyde) , retinoic acid (vitamin A acid) , or an ester of retinol and of a C 2 -C 20 acid, such as the propionate, the acetate, the linoleate or the palmitate of retinol (retinyl palmitate) , among others.
- the retinoid is selected from retinol, retinal, retinoic acid, esters of retinol and of a C 2 -C 20 acid, and a combination thereof.
- retinoids mention may more particularly be made of retinol, retinal, retinoic acid, in particular all-trans retinoic acid and 13-cis retinoic acid, retinol derivatives, such as retinyl acetate, propionate or palmitate, and the retinoids described in the following patent applications: FR 2 370 377, EP 0 199 636, EP 0 325 540 and EP 0 402 072.
- the retinoid is retinol or a pro-retinol.
- retinol is intended to mean all the isomers of retinol, i.e. all-trans retinol, 13-cis retinol, 11-cis retinol, 9-cis retinol and 3, 4-didehydro retinol.
- retinyl palmitate the palmitate of retinol
- the retinoid is selected from retinol, retinyl palmitate, and a combination thereof.
- the composition according to the present invention comprises retinol and/or retinyl palmitate.
- the retinoid is present in an amount ranging from 0.1 wt.%to 5 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
- composition according to the present invention an antioxidant combination of i) ascorbic acid or its derivative, ii) tocopherol or its derivative, and iii) at least one hydroxyhydrocinnamate antioxidant.
- derivatives of ascorbic acid include aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, magnesium ascorbyl phosphate, among others.
- the composition according to the present invention comprises one or more of ascorbic acid, aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, magnesium ascorbyl phosphate.
- the composition according to the present invention comprises ascorbic acid and/or ascorbyl glucoside.
- ascorbic acid or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
- derivatives of tocopherol include tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, dioleyl tocopheryl methylsilanol, among others.
- the composition according to the present invention comprises one or more of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, and dioleyl tocopheryl methylsilanol.
- composition according to the present invention comprises tocopherol.
- tocopherol or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
- the hydroxyhydrocinnamate antioxidant is selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
- the hydroxyhydrocinnamate antioxidant is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt.%, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
- composition of the present invention may comprise an aqueous phase.
- Said aqueous phase comprises water.
- the aqueous phase comprises an organic solvent miscible with water (at room temperature 25°C) selected from glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and combinations thereof, so as to provide a hydration effect.
- an organic solvent miscible with water selected from glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and combinations thereof, so as to provide
- the aqueous phase is present in the composition of the present invention in an amount ranging from 50%to 95%by weight, preferably from 60%to 85%by weight, relative to the total weight of the composition.
- composition of the present invention may comprise an oily phase.
- Said oily phase comprise at least one oil.
- the oil can be volatile or non-volatile.
- oil means a water-immiscible non-aqueous compound that is liquid at room temperature (25°C) and at atmospheric pressure (760 mmHg) .
- non-volatile oil means an oil that may remain on keratin materials at room temperature and atmospheric pressure for at least several hours and that especially has a vapour pressure of less than 10 -3 mmHg (0.13 Pa) .
- a non-volatile oil may also be defined as having an evaporation rate such that, under the conditions defined previously, the amount evaporated after 30 minutes is less than 0.07 mg/cm 2 .
- oils may be of plant, mineral or synthetic origin.
- Said oil can be selected from hydrocarbon-based, silicone or fluorinated oils.
- hydrocarbon-based oil means an oil formed essentially from, or even constituted by, carbon and hydrogen atoms, and optionally O and N atoms, and free of Si and F heteroatoms. Such oil can contain alcohol, ester, ether, carboxylic acid, amine and/or amide groups.
- silicon oil means an oil containing at least one silicon atom, especially containing Si-O groups.
- fluorinated oil means an oil containing at least one fluorine atom.
- the oil is selected from hydrocarbon-based oils.
- the oily phase is present in the composition of the present invention in an amount ranging from 1 wt. %to 20 wt. %, preferably from 2 wt. %to 10 wt. %, relative to the total weight of the composition of the present invention.
- composition according to the present invention can comprises one or more additional cosmetic active ingredients.
- enzymes for example, enzymes; flavonoids; humetants (for example, biosaccharide gum-1, mannose, sodium hyaluronate) ; tensioning agents; soothing agents; among others.
- composition of the present invention may comprise conventional cosmetic adjuvants or additives, for instance, fragrances, surfactants (for example, non-ionic surfactants) , chelating agents (for example, trisodium ethylenediamine disuccinate) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides (for example, hydroxyacetophenone) , thickeners (for example, xanthan gum, ammonium polyacryloyldimethyl taurate) , pH adjusting agents (for example, sodium citrate) , and combinations thereof.
- fragrances for instance, fragrances, surfactants (for example, non-ionic surfactants) , chelating agents (for example, trisodium ethylenediamine disuccinate) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides (for example, hydroxyacetophenone) , thickeners (for example, xanthan gum, ammonium polyacryloyld
- the present invention provides a composition for caring for keratin materials comprising, relative to the total weight of the composition:
- hydroxyhydrocinnamate antioxidant selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
- composition of the present invention may be in the form of gel, lotion, or emulsion.
- composition according to the present invention can be impregnated into a mask tissue to form a mask.
- the present invention relates to a mask for caring for keratin materials, comprising:
- the mask according to the present invention comprises a hydrophilic mask tissue.
- the mask tissue is water-insoluble.
- water-insoluble means that the mask tissue is not dissolvable in water and it doesn’ t break apart upon immersion in water.
- the skilled in the art can choose a suitable mask tissue and the weight ratio of the mask tissue used and the composition according to the present invention based on the nature of the composition.
- the mask tissue can be a woven or non-woven fabric.
- the mask tissue is an alginate tissue.
- Alginate tissues are known in the art and are described in WO2020001069A1.
- an alginate tissue may comprise a water-insoluble alginate chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a combination thereof, preferably calcium alginate, preferably in an amount ranging from 20 wt. %to 100 wt. %, relative to the total weight of the tissue.
- the composition according to the present invention comprises a pH adjusting agent selected from sodium acetate, sodium citrate, sodium tartrate, and a combination thereof in an amount ranging from 0.01 wt. %to 1.0 wt. %, preferably from 0.05 wt. %to 0.45 wt. %, more preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition according to the present invention.
- a pH adjusting agent selected from sodium acetate, sodium citrate, sodium tartrate, and a combination thereof in an amount ranging from 0.01 wt. %to 1.0 wt. %, preferably from 0.05 wt. %to 0.45 wt. %, more preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition according to the present invention.
- the mask tissue may be consisted of one or more layers. If a multilayer tissue is used, the material of each layer may be the same or different from each other.
- the multilayer tissue can be prepared by laminating multiple layers made from the materials mentioned above.
- the mask tissue can have a wide variety of shapes, depending on the desired use and characteristic of the mask.
- the mask tissue is typically designed to fit the area of the skin to which topical application is desired.
- the mask tissue is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary.
- the weight ratio of the water insoluble substrate and the composition ranges from 1: 3 to 1: 20. More preferably, the weight ratio of the water insoluble substrate and the composition ranges from 1: 10 to 1: 18.
- composition or mask according to the present invention is intended for topical application and can especially be used for caring for keratin materials, and especially the skin.
- composition according to the present invention can be used for anti-wrinkling.
- the present invention provides a non-therapeutic process for caring for keratin materials, in particular the skin, comprising the step of applying the composition or the mask as defined above on the keratin materials.
- the keratin materials are facial skin and/or eye skin.
- the present invention provides a non-therapeutic process for caring for keratin materials, in particular skin, comprising:
- compositions according to invention example (IE. ) 1 and comparative examples (CE. ) 1-4 were prepared with the ingredients listed in Table 2 (the contents are expressed as weight percentages of active material with regard to the total weight of each composition, unless otherwise indicated) :
- Composition of invention example 1 represents composition according to the present invention.
- Composition of comparative example 1 does not comprise an antioxidant.
- Composition of comparative example 2 does not comprise ascorbic acid or its derivative.
- Composition of comparative example 3 does not comprise ascorbic acid or its derivative, and hydroxyhydrocinnamate antioxidant.
- Composition of comparative example 4 does not comprise ascorbic acid or its derivative, and tocopherol or its derivative.
- composition of invention example 1 for illustration:
- Invention examples 2-4 and comparative example 5 were carried out to study the delivery capacity for retinyl palmitate with different mask tissues.
- the composition listed in Table 4 was used in each of invention examples 2-4 and comparative example 5.
- invention example (IE. ) 4 20 g of the composition in Table 4 was impregnated into a tissue comprising 100 wt. %of alginate fiber derived from seaweed relative to the total weight of the tissue for 12 hours, wherein the weight ratio of the tissue and the composition is 1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.
- comparative example (CE. ) 5 20 g of the composition in Table 4 was impregnated into a tissue made of viscose fiber, wherein the weight ratio of the water insoluble substrate and the composition is 1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
It relates to a composition for caring for keratin materials and a mask containing the same. It also relates to a non-therapeutic process for caring for keratin materials with said composition or mask.
Description
The present invention relates to a cosmetic composition and mask containing the same. In particular, the present invention relates to a composition for caring for keratin materials and a mask containing the same, as well as a non-therapeutic process for caring for keratin materials with said composition or mask.
BACKGROUND ART
Skin is the protective barrier for the human body. It protects the interior of the body form physical injury (such as trauma) and biological injury (such as bacterial, viruses or fungi) .
Skin aging is part of the aging process of human body, which not only relates to the age itself, but also closely relates to external factors, such as sunlight exposure. The light induced skin aging ( “light-aging” ) is mainly caused by sunlight irradiation, and as depletion of the ozone layer is aggravating, the light-aging of the skin becomes more and more serious, which affects the appearance of the skin.
The development of formulations dedicated to caring for the skin is permanent.
There are many challenges in formulating cosmetic compositions. Some active ingredients such as retinoids are not stable. In order to be commercially acceptable, the active ingredient contained in the cosmetic products must be stable for a certain period of time. No matter how efficacious a product is, the product will not be commercially acceptable if it deteriorates under storage conditions prior to sale.
Also, some lipophilic active ingredient such as retinoids cannot be delivered into the skin effectively.
Thus, it is still a goal to develop cosmetic products which can deliver retinoids into the skin effectively and retinoids contained therein are stable for a relatively long term.
SUMMARY OF THE INVENTION
It is an object of the present invention to develop cosmetic products, retinoids contained therein are stable for a relatively long term, for example, at least two months.
It is another object of the present invention to develop cosmetic products which can deliver retinoids into the skin effectively.
Thus, according to a first aspect, the present invention provides a composition for caring for keratin materials, comprising:
a) at least one retinoid; and
b) an antioxidant combination of
i) ascorbic acid or its derivative,
ii) tocopherol or its derivative, and
iii) at least one hydroxyhydrocinnamate antioxidant.
According to a second aspect, the present invention provides a mask for caring for keratin materials, comprising:
A) a hydrophilic mask tissue, and
B) a composition according to the present invention impregnated into the mask tissue.
According to a third aspect, the present invention also provides a non-therapeutic process for caring for keratin materials, in particular the skin, comprising the step of applying the composition or the mask according to the present invention on the keratin materials.
The inventors found that retinoids are stable for a relatively long term and can be delivered into the skin effectively.
Other subjects and characteristics, aspects and advantages of the present invention will emerge even more clearly on reading the detailed description and the examples that follow.
As used herein, unless otherwise indicated, the limits of a range of values are included within this range, in particular in the expressions "between…and…" and "from…to …” .
As used herein, the term “comprising” is to be interpreted as encompassing all specifically mentioned features as well as optional, additional, unspecified ones.
As used herein, the use of the term “comprising” also discloses the embodiment wherein no features other than the specifically mentioned features are present (i.e. “consisting of” ) .
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the field the present invention belongs to. When the definition of a term in the present description conflicts with the meaning as commonly understood by those skilled in the field the present invention belongs to, the definition described herein shall apply.
Unless otherwise specified, all numerical values expressing amount of ingredients and the like used in the description and claims are to be understood as being modified by the term “about” . Accordingly, unless indicated to the contrary, the numerical values and parameters described herein are approximate values which are capable of being changed according to the desired performance obtained as required.
As used herein, the expression "at least one" used in the present description is equivalent to the expression "one or more" .
For the purposes of the present invention, the term “keratin material” is intended to cover the skin. Facial skin and eye skin are most particularly considered according to the present invention.
As used herein, “stable” means that retinol or its derivatives contained in the mask will not decompose substantially for at least 2 months.
The composition for caring for keratin materials according to the present invention comprises:
a) at least one retinoid; and
b) an antioxidant combination of
i) ascorbic acid or its derivative,
ii) tocopherol or its derivative, and
iii) at least one hydroxyhydrocinnamate antioxidant.
Retinoids
According to the first aspect, the composition according to the present invention comprises at least one retinoid.
The retinoids according to the present invention include retinol (vitamin A) , retinal (vitamin A aldehyde) , retinoic acid (vitamin A acid) , or an ester of retinol and of a C
2-C
20 acid, such as the propionate, the acetate, the linoleate or the palmitate of retinol (retinyl palmitate) , among others.
Thus, in some embodiments, the retinoid is selected from retinol, retinal, retinoic acid, esters of retinol and of a C
2-C
20 acid, and a combination thereof.
Among the retinoids, mention may more particularly be made of retinol, retinal, retinoic acid, in particular all-trans retinoic acid and 13-cis retinoic acid, retinol derivatives, such as retinyl acetate, propionate or palmitate, and the retinoids described in the following patent applications: FR 2 370 377, EP 0 199 636, EP 0 325 540 and EP 0 402 072.
Preferably, the retinoid is retinol or a pro-retinol.
The term “retinol” is intended to mean all the isomers of retinol, i.e. all-trans retinol, 13-cis retinol, 11-cis retinol, 9-cis retinol and 3, 4-didehydro retinol.
As a representative of pro-retinol, mention may in particular be made of retinyl palmitate (the palmitate of retinol) .
Preferably, the retinoid is selected from retinol, retinyl palmitate, and a combination thereof.
Thus, in some preferred embodiments, the composition according to the present invention comprises retinol and/or retinyl palmitate.
Advantageously, the retinoid is present in an amount ranging from 0.1 wt.%to 5 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
Antioxidants
According to the first aspect, the composition according to the present invention an antioxidant combination of i) ascorbic acid or its derivative, ii) tocopherol or its derivative, and iii) at least one hydroxyhydrocinnamate antioxidant.
Ascorbic acid and its derivatives
As used herein, derivatives of ascorbic acid include aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, magnesium ascorbyl phosphate, among others.
Thus, in some embodiments, the composition according to the present invention comprises one or more of ascorbic acid, aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, magnesium ascorbyl phosphate.
Preferably, the composition according to the present invention comprises ascorbic acid and/or ascorbyl glucoside.
Advantageously, ascorbic acid or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
Tocopherol and its derivatives
As used herein, derivatives of tocopherol include tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, dioleyl tocopheryl methylsilanol, among others.
Thus, in some embodiments, the composition according to the present invention comprises one or more of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, and dioleyl tocopheryl methylsilanol.
Preferably, the composition according to the present invention comprises tocopherol.
Advantageously, tocopherol or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
Hydroxyhydrocinnamate antioxidants
Preferably, the hydroxyhydrocinnamate antioxidant is selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
Advantageously, the hydroxyhydrocinnamate antioxidant is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt.%, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
Aqueous phase
The composition of the present invention may comprise an aqueous phase.
Said aqueous phase comprises water.
Optionally, the aqueous phase comprises an organic solvent miscible with water (at room temperature 25℃) selected from glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and combinations thereof, so as to provide a hydration effect.
Advantageously, the aqueous phase is present in the composition of the present invention in an amount ranging from 50%to 95%by weight, preferably from 60%to 85%by weight, relative to the total weight of the composition.
Oily phase
The composition of the present invention may comprise an oily phase.
Said oily phase comprise at least one oil.
The oil can be volatile or non-volatile.
The term “oil” means a water-immiscible non-aqueous compound that is liquid at room temperature (25℃) and at atmospheric pressure (760 mmHg) . The term “non-volatile oil” means an oil that may remain on keratin materials at room temperature and atmospheric pressure for at least several hours and that especially has a vapour pressure of less than 10
-3 mmHg (0.13 Pa) . A non-volatile oil may also be defined as having an evaporation rate such that, under the conditions defined previously, the amount evaporated after 30 minutes is less than 0.07 mg/cm
2.
These oils may be of plant, mineral or synthetic origin.
Said oil can be selected from hydrocarbon-based, silicone or fluorinated oils.
The term “hydrocarbon-based oil” means an oil formed essentially from, or even constituted by, carbon and hydrogen atoms, and optionally O and N atoms, and free of Si and F heteroatoms. Such oil can contain alcohol, ester, ether, carboxylic acid, amine and/or amide groups.
The term “silicone oil” means an oil containing at least one silicon atom, especially containing Si-O groups.
The term “fluorinated oil” means an oil containing at least one fluorine atom.
Preferably, the oil is selected from hydrocarbon-based oils.
Advantageously, the oily phase is present in the composition of the present invention in an amount ranging from 1 wt. %to 20 wt. %, preferably from 2 wt. %to 10 wt. %, relative to the total weight of the composition of the present invention.
Additional cosmetic active ingredients
Depend on the final purpose, the composition according to the present invention can comprises one or more additional cosmetic active ingredients.
As cosmetic active ingredients that may be used in the composition of the present invention, examples that may be mentioned include enzymes; flavonoids; humetants (for example, biosaccharide gum-1, mannose, sodium hyaluronate) ; tensioning agents; soothing agents; among others.
It is easy for the skilled in the art to adjust the amount of the additional cosmetic active ingredient based on the final use of the composition according to the present invention.
Additional adjuvants or additives
The composition of the present invention may comprise conventional cosmetic adjuvants or additives, for instance, fragrances, surfactants (for example, non-ionic surfactants) , chelating agents (for example, trisodium ethylenediamine disuccinate) , preserving agents (for example, chlorphenesin and phenoxyethanol) and bactericides (for example, hydroxyacetophenone) , thickeners (for example, xanthan gum, ammonium polyacryloyldimethyl taurate) , pH adjusting agents (for example, sodium citrate) , and combinations thereof.
The skilled in the art can select the amount of the additional adjuvants or additive so as not to adversely impact the final use of the composition according to the present invention.
According to a preferred embodiment, the present invention provides a composition for caring for keratin materials comprising, relative to the total weight of the composition:
a) from 0.15 wt. %to 1 wt. %of retinol and/or retinyl palmitate; and
b) an antioxidant combination of
i) from 0.15 wt. %to 1 wt. %of ascorbic acid or ascorbyl glucoside,
ii) from 0.15 wt. %to 1 wt. %of tocopherol, and
iii) from 0.15 wt. %to 1 wt. %of at least one hydroxyhydrocinnamate antioxidant selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
Galenic form
The composition of the present invention may be in the form of gel, lotion, or emulsion.
Masks
The composition according to the present invention can be impregnated into a mask tissue to form a mask.
According to the second aspect, the present invention relates to a mask for caring for keratin materials, comprising:
A) a hydrophilic mask tissue, and
B) a composition according to the present invention impregnated into the mask tissue.
Hydrophilic mask tissues
According to the first aspect, the mask according to the present invention comprises a hydrophilic mask tissue.
Preferably, the mask tissue is water-insoluble.
For the purpose of the invention, the term “water-insoluble” means that the mask tissue is not dissolvable in water and it doesn’ t break apart upon immersion in water.
The skilled in the art can choose a suitable mask tissue and the weight ratio of the mask tissue used and the composition according to the present invention based on the nature of the composition.
The mask tissue can be a woven or non-woven fabric.
Preferably, the mask tissue is an alginate tissue.
Alginate tissues are known in the art and are described in WO2020001069A1.
For example, an alginate tissue may comprise a water-insoluble alginate chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a combination thereof, preferably calcium alginate, preferably in an amount ranging from 20 wt. %to 100 wt. %, relative to the total weight of the tissue.
Preferably, when the mask tissue is an alginate tissue, the composition according to the present invention comprises a pH adjusting agent selected from sodium acetate, sodium citrate, sodium tartrate, and a combination thereof in an amount ranging from 0.01 wt. %to 1.0 wt. %, preferably from 0.05 wt. %to 0.45 wt. %, more preferably from 0.15 wt. %to 0.3 wt. %, relative to the total weight of the composition according to the present invention.
The mask tissue may be consisted of one or more layers. If a multilayer tissue is used, the material of each layer may be the same or different from each other. The multilayer tissue can be prepared by laminating multiple layers made from the materials mentioned above.
The mask tissue can have a wide variety of shapes, depending on the desired use and characteristic of the mask.
The mask tissue is typically designed to fit the area of the skin to which topical application is desired. For example, when the mask is applied to the face, the mask tissue is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary.
Preferably, the weight ratio of the water insoluble substrate and the composition ranges from 1: 3 to 1: 20. More preferably, the weight ratio of the water insoluble substrate and the composition ranges from 1: 10 to 1: 18.
Use
The composition or mask according to the present invention is intended for topical application and can especially be used for caring for keratin materials, and especially the skin.
In particular, the composition according to the present invention can be used for anti-wrinkling.
According to the third aspect, the present invention provides a non-therapeutic process for caring for keratin materials, in particular the skin, comprising the step of applying the composition or the mask as defined above on the keratin materials.
In particular, the keratin materials are facial skin and/or eye skin.
In some embodiments, the present invention provides a non-therapeutic process for caring for keratin materials, in particular skin, comprising:
applying the mask according to the present invention on the keratin materials;
allowing the mask to remain on the keratin materials for a period of time; and
removing the mask from the keratin materials.
The present invention is illustrated in greater detail by the examples described below, which are given as non-limiting illustrations.
Examples
Main raw materials used, trade names and supplier thereof are listed in Table 1.
Table 1
Invention Example 1 and Comparative Examples 1-4
Compositions according to invention example (IE. ) 1 and comparative examples (CE. ) 1-4 were prepared with the ingredients listed in Table 2 (the contents are expressed as weight percentages of active material with regard to the total weight of each composition, unless otherwise indicated) :
Table 2
Composition of invention example 1 represents composition according to the present invention.
Composition of comparative example 1 does not comprise an antioxidant.
Composition of comparative example 2 does not comprise ascorbic acid or its derivative.
Composition of comparative example 3 does not comprise ascorbic acid or its derivative, and hydroxyhydrocinnamate antioxidant.
Composition of comparative example 4 does not comprise ascorbic acid or its derivative, and tocopherol or its derivative.
Preparation procedure:
Each composition was prepared as follows, taking composition of invention example 1 for illustration:
1) . adding water (40 wt. %of the total amount of water) , xanthan Gum, citric acid, and sodium citrate into a blender, heating to 75 ℃ with stirring;
2) . adding dicaprylyl ether, PEG-6 caprylic/capric glycerides, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, dicaprylyl carbonate, PPG-6-decyltetradeceth-30, octyldodecanol, and glyceryl isostearate into the blender, heating to Mixing and heating to 75 ℃ with stirring;
3) . adding tocopherol into the blender to obtain an emulsion;
4) . adding water (39.5 wt. %of the total amount of water) into the blender to dilute the emulsion;
5) . adding ammonium polyacryloyldimethyl taurate into the blender to jellify the emulsion;
6) cooling the obtained system to 30℃;
7) adding ascorbyl glucoside into the blender with stirring;
8) cooling the obtained system to 30℃; and
9) adding retinyl palmitate with stirring to obtain an uniform composition, then discharging it via a 80 mesh filter.
Evaluation:
The contents of retinyl palmitate of the compositions of invention example 1 and comparative examples 1-4 were tested upon preparation (T0) and after being remained at 55 ℃ for one week (T1W) . The results are summarized in Table 3.
Table 3
It can be seen from Table 3 that retinyl palmitate is more stable in the composition of invention example 1, as compared with compositions of comparative examples 1-4.
Invention Examples 2-4 and Comparative Example 5
Invention examples 2-4 and comparative example 5 were carried out to study the delivery capacity for retinyl palmitate with different mask tissues. The composition listed in Table 4 was used in each of invention examples 2-4 and comparative example 5.
Table 4
*:The indicated amount is based on the total amount of the composition.
In invention example (IE. ) 2, 20 g of the composition in Table 4 was impregnated into a tissue comprising 20 wt. %of alginate fiber derived from seaweed and 80 wt. %of Tencel fiber relative to the total weight of the tissue for 12 hours, wherein the weight ratio of the issue and the composition is 1: 13.5. Then the tissue was squeezed and the composition squeezed out from the tissue was dissolved in isopropanol. The solution obtained was stirred for 0.5 hours and filtrated for a Ultra-high Performance Liquid Chromatography (UPLC) analysis and the retinyl palmitate was quantified by a standard method to determine the content of retinyl palmitate in the composition squeezed out.
In invention example (IE. ) 3, 20 g of the composition in Table 4 was impregnated into a tissue comprising 50 wt. %of alginate fiber derived from seaweed and 50 wt. %of Tencel fiber relative to the total weight of the tissue for 12 hours, wherein the weight ratio of the tissue and the composition is1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.
In invention example (IE. ) 4, 20 g of the composition in Table 4 was impregnated into a tissue comprising 100 wt. %of alginate fiber derived from seaweed relative to the total weight of the tissue for 12 hours, wherein the weight ratio of the tissue and the composition is 1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.
In comparative example (CE. ) 5, 20 g of the composition in Table 4 was impregnated into a tissue made of viscose fiber, wherein the weight ratio of the water insoluble substrate and the composition is 1: 13.5. Then the procedure of invention example 2 was followed to determine the content of retinyl palmitate in the composition squeezed out.
The content of retinyl palmitate in each composition squeezed out in invention examples 2-4 and comparative example 5 are summarized in Table 5.
Table 5
RETINYL PALMITATE (%) | |
IE. 2 | 0.19 |
IE. 3 | 0.2 |
IE. 4 | 0.2 |
CE. 5 | 0.18 |
It can be seen from Table 5 that the content of Retinyl Palmitate is higher when impregnated into alginate tissues as compared with tissue made of viscose fiber. And the dosage will get higher as the composition of alginate fiber increased in the tissue.
Claims (13)
- A composition for caring for keratin materials, comprising:a) at least one retinoid; andb) an antioxidant combination ofi) ascorbic acid or its derivative,ii) tocopherol or its derivative, andiii) at least one hydroxyhydrocinnamate antioxidant.
- Composition of claim 1, wherein the retinoid is selected from retinol, retinal, retinoic acid, esters of retinol and of a C 2-C 20 acid, and a combination thereof, preferably, the retinoid is selected from retinol, retinyl palmitate, and a combination thereof.
- The composition according to Claim 1 or 2, wherein the retinoid is present in an amount ranging from 0.1 wt. %to 5 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
- Composition of any of claims 1 to 3, comprising one or more of ascorbic acid, aminopropyl ascorbyl phosphate, ascorbic acid polypeptide, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl linoleate, ascorbyl methylsilanol pectinate, ascorbyl palmitate, ascorbyl tetraisopalmitate, trisodium ascorbyl palmitate phosphate, disodium ascorbyl sulfate, calcium ascorbate, methylsilanol ascorbate, sodium ascorbate, sodium ascorbyl phosphate, sodium ascorbyl/cholesteryl phosphate, tetrahexyldecyl ascorbate, and magnesium ascorbyl phosphate, preferably the composition comprises ascorbic acid and/or ascorbyl glucoside.
- Composition of any of claims 1 to 4, wherein ascorbic acid or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt.%, relative to the total weight of the composition.
- Composition of any of claims 1 to 5, comprising one or more of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl retinoate, sodium tocopheryl phosphate, and dioleyl tocopheryl methylsilanol, preferably, the composition comprises tocopherol.
- Composition of any of claims 1 to 6, wherein tocopherol or its derivative is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt.%, relative to the total weight of the composition.
- Composition according to any of claims 1 to 7, wherein the hydroxyhydrocinnamate antioxidant is selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
- Composition according to any of claims 1 to 8, wherein the hydroxyhydrocinnamate antioxidant is present in an amount ranging from 0.05 wt. %to 3 wt. %, preferably from 0.1 wt. %to 2 wt. %, more preferably from 0.15 wt. %to 1 wt. %, relative to the total weight of the composition.
- Composition according to claim 1 comprising, relative to the total weight of the composition:a) from 0.15 wt. %to 1 wt. %of retinol and/or retinyl palmitate; andb) an antioxidant combination ofi) from 0.15 wt. %to 1 wt. %of ascorbic acid or ascorbyl glucoside,ii) from 0.15 wt. %to 1 wt. %of tocopherol, andiii) from 0.15 wt. %to 1 wt. %of at least onehydroxyhydrocinnamate antioxidant selected from pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, octadecyl di-t-butyl-4-hydroxyhydrocinnamate, tetradibutyl pentaerithrityl hydroxylhydrocinnamate, and a combination thereof.
- A mask for caring for keratin materials, comprising:A) a hydrophilic mask tissue, andB) a composition according to any of claims 1-10 impregnated into the mask tissue.
- Mask according to claim 11, wherein the water insoluble mask tissue is an alginate tissue comprising a water insoluble alginate chosen from calcium alginate, strontium alginate, zinc alginate, copper alginate, manganese alginate, or a combination thereof, preferably calcium alginate, preferably in an amount ranging from 20 wt. %to 100 wt.%, preferably from 20 wt. %to 50 wt. %, relative to the total weight of the tissue.
- A non-therapeutic process for caring for keratin materials, comprising the step of applying the composition of any of claims 1 to 10 or the mask of claim 11 or 12 on the keratin materials.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/116226 WO2024045049A1 (en) | 2022-08-31 | 2022-08-31 | Composition for caring for keratin materials and mask containing the same |
FR2210338A FR3139006A1 (en) | 2022-08-31 | 2022-10-10 | Composition for the care of keratinous materials and mask containing it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/116226 WO2024045049A1 (en) | 2022-08-31 | 2022-08-31 | Composition for caring for keratin materials and mask containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024045049A1 true WO2024045049A1 (en) | 2024-03-07 |
Family
ID=90014927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/116226 WO2024045049A1 (en) | 2022-08-31 | 2022-08-31 | Composition for caring for keratin materials and mask containing the same |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3139006A1 (en) |
WO (1) | WO2024045049A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014145034A1 (en) * | 2013-03-15 | 2014-09-18 | Laboratory Skin Care, Inc. | Fine dry particulate retinoid active agent compositions and topical formulations including the same |
WO2017180440A1 (en) * | 2016-04-11 | 2017-10-19 | Amcol International Corporation | Delivery system based on a natural microparticle for use in personal care and other topical applications |
CN108456995A (en) * | 2018-01-22 | 2018-08-28 | 潍坊爱普长实化工有限公司 | A kind of high hydroscopicity nonwoven fabric and its production technology and application |
WO2020001069A1 (en) * | 2018-06-28 | 2020-01-02 | L'oreal | Kit for caring for the skin |
WO2021250008A1 (en) * | 2020-06-08 | 2021-12-16 | L'oreal | Retinol-based composition |
WO2021250001A1 (en) * | 2020-06-08 | 2021-12-16 | L'oreal | Retinol-based composition |
WO2022006054A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic compositions having stabilized retinol |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2650851A1 (en) | 1976-11-06 | 1978-05-11 | Bosch Gmbh Robert | POWER SUPPLY DEVICE FOR A DUAL-VOLTAGE SYSTEM IN A MOTOR VEHICLE |
LU85849A1 (en) | 1985-04-11 | 1986-11-05 | Cird | BENZONAPHTHALENIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THE PHARMACEUTICAL AND COSMETIC FIELDS |
LU87109A1 (en) | 1988-01-20 | 1989-08-30 | Cird | AROMATIC ESTERS AND THIOESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS |
JPH03119163A (en) | 1989-06-05 | 1991-05-21 | Sequa Chemicals Inc | Binder for non-woven fiber |
WO2020093206A1 (en) * | 2018-11-05 | 2020-05-14 | L'oreal | Kit for caring for the skin |
WO2020133308A1 (en) * | 2018-12-29 | 2020-07-02 | L'oreal | Kit for caring for the skin |
CN117279614A (en) * | 2021-03-31 | 2023-12-22 | 莱雅公司 | Composition for caring skin and package for containing the same |
-
2022
- 2022-08-31 WO PCT/CN2022/116226 patent/WO2024045049A1/en unknown
- 2022-10-10 FR FR2210338A patent/FR3139006A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014145034A1 (en) * | 2013-03-15 | 2014-09-18 | Laboratory Skin Care, Inc. | Fine dry particulate retinoid active agent compositions and topical formulations including the same |
WO2017180440A1 (en) * | 2016-04-11 | 2017-10-19 | Amcol International Corporation | Delivery system based on a natural microparticle for use in personal care and other topical applications |
CN108456995A (en) * | 2018-01-22 | 2018-08-28 | 潍坊爱普长实化工有限公司 | A kind of high hydroscopicity nonwoven fabric and its production technology and application |
WO2020001069A1 (en) * | 2018-06-28 | 2020-01-02 | L'oreal | Kit for caring for the skin |
WO2021250008A1 (en) * | 2020-06-08 | 2021-12-16 | L'oreal | Retinol-based composition |
WO2021250001A1 (en) * | 2020-06-08 | 2021-12-16 | L'oreal | Retinol-based composition |
WO2022006054A1 (en) * | 2020-06-30 | 2022-01-06 | L'oreal | Cosmetic compositions having stabilized retinol |
Also Published As
Publication number | Publication date |
---|---|
FR3139006A1 (en) | 2024-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5572318B2 (en) | Arginine heteromer for topical administration | |
KR101868263B1 (en) | moisturizing cosmetic composition | |
US9468597B1 (en) | Stabilized L-ascorbic acid skin serum | |
US9248167B2 (en) | Exfoliative hair retention-promoting formulation | |
JP7450324B2 (en) | Composition containing D-chiro-inositol | |
KR20080070621A (en) | Novel skin care compositions | |
KR20180109329A (en) | Cosmetic composition containing moisturizing complex | |
CN112691070A (en) | Anti-aging composition, eye cream and preparation method thereof | |
EP3203977B1 (en) | Dermatological kit comprising compositions based on hibiscus flower and buriti oil | |
KR101868481B1 (en) | Cosmetic composition for moisturizing skin with snowflake pattern and method of thereof | |
KR101418366B1 (en) | Composition containing bee venom and propolis for preventing or treating acne | |
WO2024045049A1 (en) | Composition for caring for keratin materials and mask containing the same | |
JP2009001575A (en) | Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical) | |
KR101221475B1 (en) | Cosmetic Composition for Improving Acnes | |
US9801796B2 (en) | Use of parfumery compounds against hair regrowth | |
KR102419399B1 (en) | Cica-care cream composition and manufacturing method thereof | |
JP2020015699A (en) | Skin cosmetics | |
WO2023042911A1 (en) | Anti-armpit-odor composition | |
AU2021103390A4 (en) | A Skincare Oil | |
JP6651084B1 (en) | Composition containing extract of yuzu seed and brown rice | |
CN107961201B (en) | Skin-refreshing compound and application thereof | |
EP2056779A2 (en) | Use of a composition for skin treatment during x-ray irradiation | |
JP2002524405A (en) | Methods and compositions for enhancing the effect of vitamin A on cellular activity of an individual, and use of vitamin C | |
JP2008184395A (en) | Anti-perspiration and deodorization cosmetic, and method for producing the same | |
CN117243846A (en) | Fullerene retinol composition, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22956878 Country of ref document: EP Kind code of ref document: A1 |